发现一种高效的抗炎药物 - - 乳,该乳来源于epoxyisoprostane
Julian Egger1, Peter Bretscher, Stefan Freigang
1Laboratory of Organic Chemistry, ETH Zurich , HCI H335, Wolfgang-Pauli-Strasse 10, 8093 Zurich, Switzerland.
环氧易索普罗斯坦 (EI和EC) 能够有效地抑制促炎性细胞因子. 确定了一种强大的乳衍生物,可能由EI和EC形成,揭示了一种新的分子机制.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 有机化学 有机化学
背景情况:
- 乙氧化 (EI和EC) 是已知的炎症前的细胞因子分泌的抑制剂.
- 洲际素-6 (IL-6) 和洲际素-12 (IL-12) 是关键的细胞因子,参与炎症反应.
研究的目的:
- 为了研究环氧化素EI和EC的分子作用机制.
- 识别新型衍生品并了解它们的形成途径.
主要方法:
- 对Epoxyisoprostane EI (1) 和EC (2) 进行了详细的化学研究.
- 分析涉及调查分子内反应和识别产生的化合物.
主要成果:
- 鉴定出一种高强度的乳衍生物 (3).
- 异质类药物EI (1) 和EC (2) 被提议作为乳的前体 (3).
- 乳 (3) 通过EC (2) 中的环氧和碳酸之间的分子内反应形成.
结论:
- 环氧化EI和EC通过抑制IL-6和IL-12分泌而表现出强大的抗炎性质.
- 已经确定了一种新型,高强度的乳衍生物 (3),它来自EI和EC.
- 来自EI和EC的乳 (3) 的形成为这些化合物的分子通路提供了洞察力.
更多相关视频
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
08:56Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
Published on: November 30, 2022
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Preparation of Epoxides
Epoxides result from alkene oxidation, which can be achieved by a) air, b) peroxy acids, c) hypochlorous acids, and d) halohydrin cyclization.
Epoxidation with Peroxy Acids
Epoxidation of alkenes via oxidation with peroxy acids involves the conversion of a carbon–carbon double bond to an epoxide using the oxidizing agent meta-chloroperoxybenzoic acid, commonly known as MCPBA. Since the O–O bond of peroxy acids is very weak, the addition of electrophilic oxygen of peroxy...
Acid-Catalyzed Ring-Opening of Epoxides
Sharpless Epoxidation
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
